MFG
CORT icon

Magnus Financial Group’s Corcept Therapeutics CORT Stock Holding History

Magnus Financial Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,055
Closed -$169K – 376
2020
Q2 		$169K Sell
10,055
-398
-4% -$5.59K 0.02% 600
2020
Q1 		$124K Buy
+10,453
New +$129K 0.02% 504
2019
Q2 		– Sell
-11,108
Closed -$130K – 547
2019
Q1 		$130K Sell
11,108
-1,263
-10% -$15.7K 0.03% 469
2018
Q4 		$165K Buy
+12,371
New +$164K 0.04% 375

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Magnus Financial Group's CORT Position: Q3 2020 in Review

Magnus Financial Group sold out of Corcept Therapeutics (CORT) in Q3 2020, closing a stake of 10,055 shares — an estimated $169K sold.

Magnus Financial Group first reported a position in CORT in Q4 2018 and held it in 4 quarters. The position peaked at $169K in Q2 2020. 223 funds tracked by Wall St. Rank hold CORT as of Q3 2020.

  • Magnus Financial Group reported no remaining Corcept Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Magnus Financial Group sold 10,055 Corcept Therapeutics shares in Q3 2020, an estimated $169K.
  • Magnus Financial Group first reported a position in Corcept Therapeutics in Q4 2018 and held it in 4 quarters.
  • Magnus Financial Group's Corcept Therapeutics position peaked at $169K in Q2 2020.
  • 223 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.